Pharma D-mand published the book 'Feasibility to Phase I: How Early Development Decisions Save Time and Cost' by Leni Breuers, Project and Laboratory Manager R&D, AdhexPharma, on 17 September 2026.
Public source
Publisher name
Public post
Learn the assessment framework that determines whether your API will work for oral films or transdermal patches, before you commit resources. Some APIs naturally permeat…
Company
Pharma D-mand
Webinar Services, Executive Networking Events and our Industry Intelligence publication for Pharma, Biotech and MedTech.
- Industry
- Advertising Services
- Location
- Kent, GB
- Company size
- 11–50 employees
About Pharma D-mand
Pharma D-mand delivers premium webinar services, executive networking events and industry intelligence for Pharma, Biotech and MedTech organisations. We connect life sciences brands with the right decision-makers, from internal champions to C-suite leaders, through highly targeted digital engagement, exclusive executive events and an industry intelligence publication built for the sector. Partnering with Pharma D-mand will: - Give you direct access to a qualified life sciences audience aligned to your commercial objectives -Deliver content and experiences that engage the right job functions at the right time -Work within your timelines and budgets to maximise value at every stage of the campaign From concept to commercialisation, we help life sciences organisations build visibility, generate demand and foster the relationships that drive real business outcomes.
See moreLatest activity
Latest activity from Pharma D-mand
7 signals
Presence & Recognition
Pharma D-mand is featured in Terumo's Hypodermic Needle Co-Packing Strategy – Injectable Therapy event on 24th September 2026.
Research & Knowledge
Pharma D-mand launched its new Industry Intelligence for Life Sciences exploring how pharma leaders are responding to the patent cliff.
Presence & Recognition
Pharma D-mand featured presenter Leni Breuers at AdhexPharma on 17 September 2026 to teach the decision making framework for early development.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
3Biotech
3Biotech published a Drug Development Roadmap whitepaper including practical guidance and downloadable Gantt charts to help visualize the journey from discovery to first-in-human studies.
Research & Knowledge
PEIX Health Group
PEIX Health Group published data showing that AG Pro Biosimilars for 2025 showed a significant shift in the biosimilars market with 24 active biosimilars, 160 million day therapy doses, and savings of 2.1 million euros for the GKV.
Research & Knowledge
Medicines Discovery Catapult
Medicines Discovery Catapult featured Dr Emma V. Jones as one of 47 scientists in the book 'Scientists Making a Difference' by Dr Shini Somara
Research & Knowledge
Frontier Clinical Trials Ltd
Frontier Clinical Trials Ltd published a report from Global Genes involving patient communities early and keeping them involved throughout the process.
Research & Knowledge
Lovelace Biomedical